| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |